Sharps Technology

STSS

Market cap $234M

Overview Fund Activity

9.12 USD

-0.18

1.94%

At close Updated Sep 12, 4:00 PM EDT

Pre-market

After hours

9.21

+0.09

0.99%

1 day

-1.94%

5 days

-15.16%

1 month

68.89%

3 months

54.84%

6 months

-89.82%

Year to date

-98.56%

1 year

-99.47%

5 years

-99.93%

10 years

-99.93%

About: Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.

Employees: 55

Healthcare Medical Instruments & Supplies

0

Funds holding %

of 7,462 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

0.11% less ownership

Funds ownership: 0.54% [Q1] → 0.43% (-0.11%) [Q2]

46% less funds holding

Funds holding: 13 [Q1] → 7 (-6) [Q2]

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

95% less capital invested

Capital invested by funds: $528K [Q1] → $24K (-$504K) [Q2]

See Fund Rankings

Financial journalist opinion

Based on 5 articles about STSS published over the past 30 days

Sharps Technology and Pudgy Penguins Announce Strategic Partnership

NEW YORK , Sept. 10, 2025 /PRNewswire/ -- Sharps Technology ("Sharps Technology" or the "Company") (NASDAQ: STSS), a leading publicly listed Solana treasury, and Pudgy Penguins, the globally recognized Web3 brand, today announced a strategic partnership to bring exposure and connectivity to the Solana digital asset treasury space.

Sharps Technology and Pudgy Penguins Announce Strategic Partnership

Sharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public Blockchain

NEW YORK , Sept. 2, 2025 /PRNewswire/ -- Sharps Technology, Inc. (the "Company" or "Sharps Technology") (Nasdaq: "STSS" and "STSSW") today announced its first acquisition of Solana ("SOL") tokens as part of its digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain.

Sharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public Blockchain

Sharps Technology, Inc. Closes Over $400 Million Private Placement, Launching Solana Digital Asset Treasury Strategy

Transaction could raise up to $1 billion in aggregate gross proceeds if all of the warrants are exercised, which would make Sharps Technology one of the largest Solana treasury companies Subscribers included preeminent financial institutions and digital asset market leaders such as ParaFi, Pantera, Monarq, FalconX, Phoenix Digital, Bastion Trading, RockawayX, Syncracy, Borderless, Republic Digital, Arche Capital, Arrington Capital, Hypersphere, Quantstamp, FinTech Collective, CoinList Alpha, Primitive Ventures, Avenir Group, Luca Netz, Cube, and Saba Capital, among others NEW YORK , Aug. 28, 2025 /PRNewswire/ -- Sharps Technology, Inc. (the "Company" or "Sharps Technology") (Nasdaq: "STSS" and "STSSW") today announced the closing of its previously announced private placement offering of common stock and stapled warrants to purchase shares of common stock at a purchase price of $6.50 per unit. The transaction generated gross proceeds of over $400 million, and an additional $600 million could be raised if all of the warrants are exercised, which could increase total proceeds to $1 billion.

Sharps Technology, Inc. Closes Over $400 Million Private Placement, Launching Solana Digital Asset Treasury Strategy

Here's why Sharps Technology stock jumped 56% on Wednesday

Sharps Technology stock (NASDAQ: STSS) surged 56% on Wednesday, following the company's announcement of a $400 million private placement to create the largest Solana blockchain-backed digital asset treasury in the corporate sector.

Here's why Sharps Technology stock jumped 56% on Wednesday

Sharps Technology, Inc. Announces over $400 Million Private Placement seeking to Establish the Largest Solana Digital Asset Treasury Strategy

Investors include leading financial institutions and digital asset market leaders such as ParaFi, Pantera, Monarq, FalconX, Phoenix Capital, Bastion Trading, RockawayX, Syncracy, Borderless, Republic Digital, Arche Capital, CoinFund, Arrington Capital, Quantstamp, CoinList Alpha, Primitive Ventures, Avenir, Hypersphere, and more NEW YORK , Aug. 25, 2025 /PRNewswire/ -- Sharps Technology, Inc. (the "Company" or "Sharps Technology") (Nasdaq: "STSS" and "STSSW") today announced the pricing of a private placement offering to support its plans to adopt a digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain. Solana is the fastest and most used public blockchain in the world, processing more transactions and generating more onchain fee revenue than all other blockchains combined.

Sharps Technology, Inc. Announces over $400 Million Private Placement seeking to Establish the Largest Solana Digital Asset Treasury Strategy

Sharps Technology Shares Climb on Latest SoloGard Shipments

Shares of Sharps Technology jumped after the company said it has initiated a second shipment from its first commercial order of SoloGard syringes.

Sharps Technology Shares Climb on Latest SoloGard Shipments

Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility Upgrades

Second commercial delivery underway as part of multi-year contract with leading U.S. healthcare partner Strategic manufacturing upgrades drive scalability, efficiency, and increases capacity to support production growth NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced an update on the execution of its first shipments under the previously announced $50 million SoloGard sales agreement, alongside a series of advanced manufacturing upgrades. Sharps has initiated the second shipment of its first commercial order of SoloGard syringes under a multi-year supply agreement with a U.S.-based leader in IV flushing solutions.

Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility Upgrades

Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on June 12th, 2025 at 9:30 AM ET. Sharps recently announced that the Company has commenced shipments under three customer orders tied to previously announced purchase agreements.

Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET

Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET

Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, will present at the Virtual Investor Summit on June 10, 2025, at 10:00 AM ET. Investors are invited to listen to the presentation and can register here.

Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025

See News Rankings

Charts implemented using Lightweight Charts™